Last reviewed · How we verify
rE-4 Freeze-dried Powder — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
rE-4 Freeze-dried Powder (rE-4 Freeze-dried Powder) — CSPC ZhongQi Pharmaceutical Technology Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| rE-4 Freeze-dried Powder TARGET | rE-4 Freeze-dried Powder | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- rE-4 Freeze-dried Powder CI watch — RSS
- rE-4 Freeze-dried Powder CI watch — Atom
- rE-4 Freeze-dried Powder CI watch — JSON
- rE-4 Freeze-dried Powder alone — RSS
Cite this brief
Drug Landscape (2026). rE-4 Freeze-dried Powder — Competitive Intelligence Brief. https://druglandscape.com/ci/re-4-freeze-dried-powder. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab